630-576-9696 Menu

No Fee Unless We Win!


English / Español

Nationwide / Available 24/7

A Closer Look at Safety Concerns

The Dexcom G6, a continuous glucose monitoring system, has received praise for its real-time monitoring capabilities. However, safety concerns have led to recalls, lawsuits, and FDA scrutiny.

The G6 system is designed to measure glucose levels around the clock using a wearable device, but many users have found that it did not live up to its promises. Since its FDA approval in 2018, there have been alarming reports. The FDA received over half a million Maude Device Reports citing product defects, with 13 linked to deaths. Users reported instances where the device failed to alert them of critical low or high blood sugar levels, leading to injuries and fatalities.

An article by Dr. Alan Shapiro in the American Medical Association highlighted issues with Dexcom's previous model, the G5, which saw thousands of reports of inaccurate readings. Despite these concerns, the FDA proceeded with approving the G6, raising questions about the thoroughness of the approval process.

Consumer complaints echoed these worries, with reports of sensors failing up to 25% of the time or more. Three separate recalls followed, addressing issues like alarm failures, temperature-related inaccuracies, and potential interference causing false readings. Despite the evidence, the FDA has not taken decisive action, citing a lack of predefined thresholds for complaint numbers. This inaction has left Dexcom's G6 on the market, potentially endangering countless users.

Recall Details

Dexcom initiated several recalls related to the G6 system's functionality in response to mounting safety concerns and user complaints. Here’s what you need to know:

Recall Triggers

  • Alarm Failures: One of the key triggers for recalls was the failure of alarm systems within the Dexcom G6 system. These alarms are critical for alerting users to dangerously low or high blood sugar levels, making their malfunction a serious safety concern.
  • Inaccurate Readings: Recalls also addressed issues related to erroneous glucose readings reported by the G6 system. Inaccuracies in glucose monitoring can lead to incorrect insulin dosing decisions, posing substantial risks to diabetic patients' health and well-being.

Regulatory Oversight

  • FDA Involvement: The recalls prompted close scrutiny from the Food and Drug Administration (FDA), the regulatory body responsible for overseeing medical devices' safety and efficacy. The FDA's involvement in monitoring the recall process and evaluating Dexcom's corrective actions is critical for ensuring ongoing compliance and user safety.
  • Compliance Challenges: Dexcom's response to the recalls and its ability to address the identified issues effectively are closely monitored by regulatory authorities. Compliance with regulatory standards and timely corrective measures are paramount to restoring trust in the Dexcom G6 system among healthcare providers and patients.

User Impact

  • Disruption of Care: The recalls disrupted the diabetes management routines of users reliant on the Dexcom G6 system for continuous glucose monitoring. Malfunctioning devices, inaccurate readings, and alarm failures can undermine users' confidence in the system's reliability and effectiveness.
  • Health Risks: The potential health risks associated with the recalled Dexcom G6 devices, such as missed low blood sugar alarms or incorrect glucose readings, have raised concerns about the system's safety and impact on users' overall health outcomes.

Corrective Measures

  • Quality Assurance: Dexcom's response to the recalls includes implementing rigorous quality assurance measures to prevent similar issues from recurring in future G6 system iterations. Enhanced testing protocols, improved alarm functionalities, and stricter manufacturing standards are among the corrective measures Dexcom has implemented.
  • User Education: Dexcom has also prioritized user education and training initiatives to ensure that G6 system users are informed about proper device use, troubleshooting procedures, and safety precautions. Empowering users with knowledge and resources is crucial for enhancing device reliability and user confidence.

Potential Compensation

  • Damages Recovery: Compensation sought in Dexcom G6 lawsuits may include economic damages (such as medical expenses, lost wages, and rehabilitation costs) and non-economic damages (such as pain and suffering, emotional distress, and loss of quality of life).
  • Punitive Damages: In cases of egregious misconduct or willful negligence, courts may award punitive damages to deter similar behavior in the future and hold Dexcom accountable for its actions or omissions regarding the G6 system's safety.

Navigating legal options for Dexcom G6 issues requires proactive engagement with experienced legal professionals who can provide guidance, support, and advocacy throughout the legal journey. By taking decisive action and seeking legal recourse, affected individuals can seek justice, hold Dexcom accountable, and contribute to efforts to enhance medical device safety standards.

Protect Your Rights: Meyers & Flowers Takes on Dexcom G6 Cases

If you or a loved one has been impacted by Dexcom G6 issues, Meyers & Flowers is here to help. Our firm is actively representing clients as local counsel on these cases, advocating for fair compensation for damages, including medical expenses, pain and suffering, and other losses caused by the G6 system's deficiencies. We are committed to seeking justice for our clients and holding Dexcom accountable for its actions or omissions related to the G6 system's safety and performance.

With years of experience in medical device litigation and product liability cases, Meyers & Flowers has the expertise and resources to navigate the complexities of Dexcom G6 legal matters. Our team of skilled attorneys specializes in representing clients in cases involving defective medical devices, ensuring that our clients' rights are protected and advocated for throughout the legal process.

Don't wait to seek legal guidance and representation. Contact Meyers & Flowers today for a confidential consultation, and let us fight for your rights and interests in Dexcom G6 cases. We are here to listen, support, and advocate for you every step of the way.

© Meyers & Flowers Trial Attorneys. All Rights Reserved. Web Design & Internet Marketing by Studio III

Privacy Policy


Contact Us